BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tammam SN, El Safy S, Ramadan S, Arjune S, Krakor E, Mathur S. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2. J Control Release 2021;337:258-84. [PMID: 34293319 DOI: 10.1016/j.jconrel.2021.07.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Tu B, Wang H, An X, Qu J, Li Q, Gao Y, Shi M, Qiu H, Huang Y. Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants. Acta Pharm Sin B 2022. [PMID: 35169535 DOI: 10.1016/j.apsb.2022.01.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sanna V, Satta S, Hsiai T, Sechi M. Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Valdivia-Olivares RY, Rodriguez-Fernandez M, Álvarez-Figueroa MJ, Kalergis AM, González-Aramundiz JV. The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination. Vaccines (Basel) 2021;9:1420. [PMID: 34960166 DOI: 10.3390/vaccines9121420] [Reference Citation Analysis]
4 Kamat S, Kumari M, Jayabaskaran C. Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2. J Control Release 2021;338:813-36. [PMID: 34478750 DOI: 10.1016/j.jconrel.2021.08.046] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tan RSL, Hassandarvish P, Chee CF, Chan LW, Wong TW. Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine. Carbohydr Polym 2022;290:119500. [PMID: 35550778 DOI: 10.1016/j.carbpol.2022.119500] [Reference Citation Analysis]